tiprankstipranks

Fady Ibraham Malik Insider Profile

4 Followers
Fady Ibraham Malik, EVP Research & Development at Cytokinetics, holds 113.88K shares in Cytokinetics (Ticker: CYTK), holds ― shares in Rocket Pharmaceuticals (Ticker: RCKT).
tipranks
Fady Ibraham Malik

Fady Ibraham Malik
Cytokinetics (CYTK)
EVP Research & Development

Ranked #86,718 out of 99,635 Corporate Insiders

Profitable Transactions

67%
14 out of 21 Profitable Transactions

Average Return

-14.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
100.00%
0.00%
A breakdown of Fady Ibraham Malik's holdings

Insider Roles

Cytokinetics
(CYTK)
EVP Research & Development
Rocket Pharmaceuticals
(RCKT)
Director
Roles that Fady Ibraham Malik holds in companies

Most Profitable Insider Trade

Stock:
Cytokinetics
(CYTK)
Rating:Informative Sell
Date:Apr 09, 2024 - Today
Return:+34.50%
The most profitable trade made by Fady Ibraham Malik

Fady Ibraham Malik's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cytokinetics
Nov 13, 2024
EVP Research & Development
Uninformative Buy
42.19K
$5.59M
Rocket Pharmaceuticals
Director
List of latest transactions for each holding click on a transaction to see Fady Ibraham Malik's performance on stock

Fady Ibraham Malik insider profile FAQ

What is the percentage of profitable transactions made by Fady Ibraham Malik?
The percentage of profitable transactions made by Fady Ibraham Malik is 67%.
    What is the average return per transaction made by Fady Ibraham Malik?
    The average return per transaction made by Fady Ibraham Malik is -14.90%.
      What stocks does Fady Ibraham Malik hold?
      Fady Ibraham Malik holds: CYTK, RCKT stocks.
        What was Fady Ibraham Malik’s latest transaction?
        Fady Ibraham Malik latest transaction was an Uninformative Buy of $42.19K.
          What was Fady Ibraham Malik's most profitable transaction?
          Fady Ibraham Malik’s most profitable transaction was an Informative Sell of CYTK stock on April 9, 2024. The return on the trade was 34.50%.
            What is Fady Ibraham Malik's role in Cytokinetics?
            Fady Ibraham Malik's role in Cytokinetics is EVP Research & Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.